

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | immunoglobulin mediated immune response (GO:0016064) | 6.58000251 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.21553794 |
| 3 | B cell mediated immunity (GO:0019724) | 5.17348366 |
| 4 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 5.08549872 |
| 5 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.05314302 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92910868 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80933873 |
| 8 | regulation of antigen processing and presentation (GO:0002577) | 4.71770460 |
| 9 | detection of bacterium (GO:0016045) | 4.64676115 |
| 10 | detection of other organism (GO:0098543) | 4.57005105 |
| 11 | positive regulation of antigen processing and presentation (GO:0002579) | 4.54608729 |
| 12 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.52096344 |
| 13 | neutrophil activation involved in immune response (GO:0002283) | 4.51045880 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.47844176 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.35129162 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.32692930 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.32692930 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.32692930 |
| 19 | positive regulation by symbiont of host defense response (GO:0052509) | 4.32692930 |
| 20 | modulation by symbiont of host defense response (GO:0052031) | 4.32692930 |
| 21 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.32692930 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28241961 |
| 23 | response to peptidoglycan (GO:0032494) | 4.14615334 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.12319948 |
| 25 | positive thymic T cell selection (GO:0045059) | 4.11539493 |
| 26 | T-helper 1 type immune response (GO:0042088) | 4.08157525 |
| 27 | * cellular response to interferon-gamma (GO:0071346) | 4.00515161 |
| 28 | positive regulation of mast cell activation (GO:0033005) | 3.99095254 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.96422838 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.96422838 |
| 31 | positive regulation of mast cell degranulation (GO:0043306) | 3.94691517 |
| 32 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.94691517 |
| 33 | positive regulation of type 2 immune response (GO:0002830) | 3.87418648 |
| 34 | * T cell costimulation (GO:0031295) | 3.80166490 |
| 35 | detection of external biotic stimulus (GO:0098581) | 3.78293005 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.75204483 |
| 37 | * lymphocyte costimulation (GO:0031294) | 3.74540043 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61691443 |
| 39 | * response to interferon-gamma (GO:0034341) | 3.60634578 |
| 40 | regulation of mast cell degranulation (GO:0043304) | 3.58974928 |
| 41 | positive regulation of B cell differentiation (GO:0045579) | 3.57656248 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.55990066 |
| 43 | regulation of hypersensitivity (GO:0002883) | 3.53257762 |
| 44 | type I interferon signaling pathway (GO:0060337) | 3.52356549 |
| 45 | cellular response to type I interferon (GO:0071357) | 3.52356549 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50309914 |
| 47 | response to type I interferon (GO:0034340) | 3.49139460 |
| 48 | microglial cell activation (GO:0001774) | 3.41718874 |
| 49 | defense response to protozoan (GO:0042832) | 3.39830488 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.38236727 |
| 51 | regulation of mast cell activation (GO:0033003) | 3.34233254 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.30876137 |
| 53 | detection of biotic stimulus (GO:0009595) | 3.30752886 |
| 54 | regulation of T cell tolerance induction (GO:0002664) | 3.30329776 |
| 55 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.28472469 |
| 56 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.27390759 |
| 57 | myeloid dendritic cell activation (GO:0001773) | 3.25025828 |
| 58 | response to protozoan (GO:0001562) | 3.18113089 |
| 59 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.16986067 |
| 60 | negative thymic T cell selection (GO:0045060) | 3.16305214 |
| 61 | regulation of tolerance induction (GO:0002643) | 3.16113958 |
| 62 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14288667 |
| 63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12858961 |
| 64 | response to host immune response (GO:0052572) | 3.12858961 |
| 65 | regulation of B cell differentiation (GO:0045577) | 3.08830507 |
| 66 | production of molecular mediator of immune response (GO:0002440) | 3.08134356 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.08021423 |
| 68 | detection of molecule of bacterial origin (GO:0032490) | 3.07824493 |
| 69 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 3.07627936 |
| 70 | myeloid dendritic cell differentiation (GO:0043011) | 3.07321767 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05793356 |
| 72 | positive T cell selection (GO:0043368) | 3.05758110 |
| 73 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.04973398 |
| 74 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.04352087 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 3.04337157 |
| 76 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.02488300 |
| 77 | regulation of interferon-alpha production (GO:0032647) | 3.01933070 |
| 78 | positive regulation of leukocyte degranulation (GO:0043302) | 3.00841462 |
| 79 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.97128262 |
| 80 | regulation of type 2 immune response (GO:0002828) | 2.95686246 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.95457341 |
| 82 | cellular extravasation (GO:0045123) | 2.95189263 |
| 83 | germinal center formation (GO:0002467) | 2.94679070 |
| 84 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94161182 |
| 85 | negative T cell selection (GO:0043383) | 2.93129780 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.93049693 |
| 87 | response to muramyl dipeptide (GO:0032495) | 2.92433425 |
| 88 | T cell migration (GO:0072678) | 2.91118714 |
| 89 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.90616739 |
| 90 | macrophage activation (GO:0042116) | 2.89644128 |
| 91 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88928752 |
| 92 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.88693410 |
| 93 | neutrophil activation (GO:0042119) | 2.87186748 |
| 94 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.87060550 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86690771 |
| 96 | T cell selection (GO:0045058) | 2.86623040 |
| 97 | granulocyte activation (GO:0036230) | 2.83798953 |
| 98 | response to host (GO:0075136) | 2.81369878 |
| 99 | response to host defenses (GO:0052200) | 2.81369878 |
| 100 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.81369878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.73139212 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.77299560 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.01460619 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.09309959 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.59270362 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56157939 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.43978982 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.30289129 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.23575982 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.20891312 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.81190743 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79348794 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.73458505 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.59889611 |
| 15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.59066098 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50856841 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41384685 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40843982 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40126321 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.34675362 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.33109853 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.30079831 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.25457942 |
| 24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.21822203 |
| 25 | SPI1_23127762_ChIP-Seq_K562_Human | 2.15652811 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.09363633 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.04803743 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04483676 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00693856 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.93990014 |
| 31 | MAF_26560356_Chip-Seq_TH1_Human | 1.89917806 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.89903500 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88446413 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.85597655 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.83906842 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79829518 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78846881 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.67716058 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.59208559 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55356442 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.53768164 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51470261 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50299833 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49382372 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46702902 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41967034 |
| 47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41918252 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.41266640 |
| 49 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40345030 |
| 50 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35955098 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35748999 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31910070 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29276279 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28093271 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25155134 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.23241955 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22411963 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22057227 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21363269 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21300535 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18863079 |
| 62 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16645635 |
| 63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15999578 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.14576570 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13931699 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13683761 |
| 67 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13515870 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11177568 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10963295 |
| 70 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.10928235 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09048732 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08100117 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03456457 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02515283 |
| 75 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.01594029 |
| 76 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01386951 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99373196 |
| 78 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97084073 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92051221 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91611188 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89909214 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87973027 |
| 83 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87615268 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85335437 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85242943 |
| 86 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82325423 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81336839 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.80286477 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80012755 |
| 90 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79850118 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.79775015 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.78751879 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78063350 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77542543 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 0.75328544 |
| 96 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75152954 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73784426 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72840923 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.70721504 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70442435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.23599028 |
| 2 | MP0005671_abnormal_response_to | 3.89227487 |
| 3 | MP0003303_peritoneal_inflammation | 3.62631488 |
| 4 | MP0003724_increased_susceptibility_to | 3.32207370 |
| 5 | MP0003436_decreased_susceptibility_to | 3.26578796 |
| 6 | MP0005387_immune_system_phenotype | 3.26178638 |
| 7 | MP0001790_abnormal_immune_system | 3.26178638 |
| 8 | MP0001800_abnormal_humoral_immune | 3.21557630 |
| 9 | MP0000685_abnormal_immune_system | 3.10633161 |
| 10 | MP0005000_abnormal_immune_tolerance | 3.03580303 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.02226399 |
| 12 | MP0009785_altered_susceptibility_to | 3.00988811 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.84383629 |
| 14 | MP0005025_abnormal_response_to | 2.79825625 |
| 15 | MP0002419_abnormal_innate_immunity | 2.78749346 |
| 16 | MP0006082_CNS_inflammation | 2.68677737 |
| 17 | MP0002723_abnormal_immune_serum | 2.68019763 |
| 18 | MP0001819_abnormal_immune_cell | 2.44664558 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.43677064 |
| 20 | MP0010155_abnormal_intestine_physiology | 2.21760192 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.14743752 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.06848201 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.95912677 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.91465283 |
| 25 | MP0001845_abnormal_inflammatory_respons | 1.89613428 |
| 26 | MP0002166_altered_tumor_susceptibility | 1.87464509 |
| 27 | MP0000716_abnormal_immune_system | 1.84829853 |
| 28 | MP0002398_abnormal_bone_marrow | 1.76813307 |
| 29 | MP0003763_abnormal_thymus_physiology | 1.76703289 |
| 30 | MP0002405_respiratory_system_inflammati | 1.72435866 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.69835322 |
| 32 | MP0009764_decreased_sensitivity_to | 1.69215968 |
| 33 | MP0003075_altered_response_to | 1.68568619 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.63048662 |
| 35 | MP0004947_skin_inflammation | 1.60209517 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.59268935 |
| 37 | MP0008469_abnormal_protein_level | 1.59189551 |
| 38 | MP0003183_abnormal_peptide_metabolism | 1.58974232 |
| 39 | MP0001853_heart_inflammation | 1.56621278 |
| 40 | MP0005166_decreased_susceptibility_to | 1.55592559 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.55371734 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.53107910 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.46384792 |
| 44 | MP0003866_abnormal_defecation | 1.45808001 |
| 45 | MP0002429_abnormal_blood_cell | 1.45448417 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.42733256 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.36205170 |
| 48 | MP0005451_abnormal_body_composition | 1.35413177 |
| 49 | MP0005310_abnormal_salivary_gland | 1.31740470 |
| 50 | MP0000343_altered_response_to | 1.31075515 |
| 51 | MP0002722_abnormal_immune_system | 1.30419037 |
| 52 | MP0002006_tumorigenesis | 1.29014166 |
| 53 | MP0009840_abnormal_foam_cell | 1.27014500 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.26591661 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.25838081 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.25838081 |
| 57 | MP0001873_stomach_inflammation | 1.25675903 |
| 58 | MP0000858_altered_metastatic_potential | 1.24271196 |
| 59 | MP0008004_abnormal_stomach_pH | 1.18046016 |
| 60 | MP0009278_abnormal_bone_marrow | 1.09745811 |
| 61 | MP0002396_abnormal_hematopoietic_system | 1.08355870 |
| 62 | MP0000604_amyloidosis | 1.06626138 |
| 63 | MP0003828_pulmonary_edema | 1.02441109 |
| 64 | MP0003448_altered_tumor_morphology | 1.01515027 |
| 65 | MP0009763_increased_sensitivity_to | 0.94794223 |
| 66 | MP0001663_abnormal_digestive_system | 0.94424160 |
| 67 | MP0008260_abnormal_autophagy | 0.91424216 |
| 68 | MP0000249_abnormal_blood_vessel | 0.85685692 |
| 69 | MP0000703_abnormal_thymus_morphology | 0.84890235 |
| 70 | MP0005165_increased_susceptibility_to | 0.83071842 |
| 71 | MP0005360_urolithiasis | 0.81989920 |
| 72 | MP0003690_abnormal_glial_cell | 0.81495167 |
| 73 | MP0004510_myositis | 0.80873444 |
| 74 | MP0001851_eye_inflammation | 0.79539274 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.78375458 |
| 76 | MP0004883_abnormal_blood_vessel | 0.72849965 |
| 77 | MP0003045_fibrosis | 0.72673833 |
| 78 | MP0000015_abnormal_ear_pigmentation | 0.70919413 |
| 79 | MP0002132_abnormal_respiratory_system | 0.70127571 |
| 80 | MP0002933_joint_inflammation | 0.69556356 |
| 81 | MP0000490_abnormal_crypts_of | 0.69017834 |
| 82 | MP0005164_abnormal_response_to | 0.67393100 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.67215016 |
| 84 | MP0002009_preneoplasia | 0.66763982 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.66240158 |
| 86 | MP0000920_abnormal_myelination | 0.64745459 |
| 87 | MP0005390_skeleton_phenotype | 0.63308115 |
| 88 | MP0009643_abnormal_urine_homeostasis | 0.62816874 |
| 89 | MP0004808_abnormal_hematopoietic_stem | 0.61036454 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59874640 |
| 91 | MP0005365_abnormal_bile_salt | 0.58640921 |
| 92 | MP0003795_abnormal_bone_structure | 0.58370615 |
| 93 | MP0003091_abnormal_cell_migration | 0.58295543 |
| 94 | MP0008874_decreased_physiological_sensi | 0.56653361 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.56516931 |
| 96 | MP0003252_abnormal_bile_duct | 0.54780534 |
| 97 | MP0000609_abnormal_liver_physiology | 0.54032684 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.53549717 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 0.53408410 |
| 100 | MP0005535_abnormal_body_temperature | 0.49799009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent bacterial skin infections (HP:0005406) | 4.87449685 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.76151071 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.69371037 |
| 4 | Meningitis (HP:0001287) | 4.47581691 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.42848222 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.38252090 |
| 7 | Obstructive lung disease (HP:0006536) | 4.28872249 |
| 8 | Chronic obstructive pulmonary disease (HP:0006510) | 4.28872249 |
| 9 | Agammaglobulinemia (HP:0004432) | 4.20568502 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 4.14204837 |
| 11 | Vasculitis (HP:0002633) | 4.07091974 |
| 12 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.82818529 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.82818529 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.76327495 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.76327495 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.76327495 |
| 17 | Pulmonary infiltrates (HP:0002113) | 3.73491772 |
| 18 | Recurrent fungal infections (HP:0002841) | 3.71149756 |
| 19 | Hemoptysis (HP:0002105) | 3.66717890 |
| 20 | Recurrent skin infections (HP:0001581) | 3.64950304 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62438975 |
| 22 | Myositis (HP:0100614) | 3.58817322 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.45483749 |
| 24 | Abnormality of the prostate (HP:0008775) | 3.45276151 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.40278250 |
| 26 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.39737308 |
| 27 | Recurrent viral infections (HP:0004429) | 3.34829082 |
| 28 | Colitis (HP:0002583) | 3.27802416 |
| 29 | Gastrointestinal stroma tumor (HP:0100723) | 3.27710044 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 3.25241472 |
| 31 | Urticaria (HP:0001025) | 3.24304184 |
| 32 | Orchitis (HP:0100796) | 3.24096101 |
| 33 | Chest pain (HP:0100749) | 3.21802201 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.18660400 |
| 35 | Optic neuritis (HP:0100653) | 3.18031254 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 3.18031254 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 3.09741295 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04909223 |
| 39 | Restrictive lung disease (HP:0002091) | 3.01214135 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.99577734 |
| 41 | Cellulitis (HP:0100658) | 2.97703174 |
| 42 | Recurrent sinusitis (HP:0011108) | 2.92954296 |
| 43 | Abnormality of the pleura (HP:0002103) | 2.92295923 |
| 44 | Inflammation of the large intestine (HP:0002037) | 2.88177215 |
| 45 | Encephalitis (HP:0002383) | 2.87696065 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.73708059 |
| 47 | Increased IgE level (HP:0003212) | 2.70772899 |
| 48 | Stomatitis (HP:0010280) | 2.69888839 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.69753519 |
| 50 | Skin rash (HP:0000988) | 2.68325813 |
| 51 | Chronic diarrhea (HP:0002028) | 2.65804758 |
| 52 | Gangrene (HP:0100758) | 2.63859636 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.62253074 |
| 54 | Osteomyelitis (HP:0002754) | 2.61693263 |
| 55 | Increased IgM level (HP:0003496) | 2.57386618 |
| 56 | Loss of speech (HP:0002371) | 2.56402163 |
| 57 | Gingivitis (HP:0000230) | 2.55870079 |
| 58 | Pulmonary embolism (HP:0002204) | 2.52289143 |
| 59 | Glomerulonephritis (HP:0000099) | 2.51530096 |
| 60 | Epistaxis (HP:0000421) | 2.49760698 |
| 61 | Pulmonary fibrosis (HP:0002206) | 2.47762868 |
| 62 | Abnormality of complement system (HP:0005339) | 2.47277380 |
| 63 | Purpura (HP:0000979) | 2.46273677 |
| 64 | Amyloidosis (HP:0011034) | 2.46002596 |
| 65 | Abnormality of T cell number (HP:0011839) | 2.44575429 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.44520494 |
| 67 | T lymphocytopenia (HP:0005403) | 2.42401554 |
| 68 | Emphysema (HP:0002097) | 2.39340719 |
| 69 | Chronic otitis media (HP:0000389) | 2.39302863 |
| 70 | Recurrent pneumonia (HP:0006532) | 2.35122974 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.34728260 |
| 72 | Petechiae (HP:0000967) | 2.34132340 |
| 73 | Pustule (HP:0200039) | 2.32301169 |
| 74 | Acrocyanosis (HP:0001063) | 2.31897725 |
| 75 | Lymphopenia (HP:0001888) | 2.31884154 |
| 76 | Arterial thrombosis (HP:0004420) | 2.30848772 |
| 77 | Abnormality of T cells (HP:0002843) | 2.29524435 |
| 78 | Hypergammaglobulinemia (HP:0010702) | 2.28712612 |
| 79 | Polyneuropathy (HP:0001271) | 2.26371143 |
| 80 | IgM deficiency (HP:0002850) | 2.26165094 |
| 81 | Glomerulopathy (HP:0100820) | 2.25813293 |
| 82 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.22818832 |
| 83 | Recurrent lower respiratory tract infections (HP:0002783) | 2.20231070 |
| 84 | Amaurosis fugax (HP:0100576) | 2.20181743 |
| 85 | Gingival bleeding (HP:0000225) | 2.20142302 |
| 86 | Xerostomia (HP:0000217) | 2.18684156 |
| 87 | Skin ulcer (HP:0200042) | 2.18545097 |
| 88 | Hypertensive crisis (HP:0100735) | 2.17092772 |
| 89 | Keratoconjunctivitis (HP:0001096) | 2.16169739 |
| 90 | Abnormality of B cell number (HP:0010975) | 2.15916135 |
| 91 | Abnormality of T cell physiology (HP:0011840) | 2.15219662 |
| 92 | Leukocytosis (HP:0001974) | 2.14659555 |
| 93 | Nephritis (HP:0000123) | 2.13169069 |
| 94 | Verrucae (HP:0200043) | 2.12261433 |
| 95 | Papilloma (HP:0012740) | 2.12261433 |
| 96 | Arthralgia (HP:0002829) | 2.10857583 |
| 97 | Malnutrition (HP:0004395) | 2.10255342 |
| 98 | Premature loss of primary teeth (HP:0006323) | 2.08788116 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.08433163 |
| 100 | Complement deficiency (HP:0004431) | 2.07637067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.34765223 |
| 2 | MAP4K1 | 4.06679866 |
| 3 | BLK | 4.02466770 |
| 4 | TYK2 | 3.25482934 |
| 5 | MAP3K14 | 2.95727691 |
| 6 | BMPR2 | 2.87222195 |
| 7 | ERN1 | 2.61786056 |
| 8 | CSF1R | 2.60854724 |
| 9 | KIT | 2.53833677 |
| 10 | JAK3 | 2.34136455 |
| 11 | SYK | 2.29678580 |
| 12 | MAP3K13 | 2.24922255 |
| 13 | FES | 2.14331472 |
| 14 | TBK1 | 2.11985572 |
| 15 | BTK | 2.02278458 |
| 16 | PRPF4B | 2.01133949 |
| 17 | IRAK4 | 1.99868273 |
| 18 | CSK | 1.96597318 |
| 19 | IKBKE | 1.92254078 |
| 20 | CDK19 | 1.84203718 |
| 21 | TXK | 1.84000762 |
| 22 | IKBKB | 1.83832713 |
| 23 | JAK1 | 1.82136713 |
| 24 | LYN | 1.74403420 |
| 25 | ZAP70 | 1.68336396 |
| 26 | TAOK3 | 1.65153396 |
| 27 | MATK | 1.53967695 |
| 28 | TEC | 1.47273985 |
| 29 | ITK | 1.41547821 |
| 30 | HCK | 1.37103594 |
| 31 | MAP2K3 | 1.31494105 |
| 32 | LCK | 1.28331975 |
| 33 | GRK7 | 1.27823383 |
| 34 | FGR | 1.26483635 |
| 35 | JAK2 | 1.18905950 |
| 36 | GRK6 | 1.15964496 |
| 37 | TNK2 | 1.07661810 |
| 38 | PIK3CG | 1.03980494 |
| 39 | CDC42BPA | 1.02026001 |
| 40 | NME2 | 0.99681034 |
| 41 | MAP3K3 | 0.99623486 |
| 42 | TGFBR2 | 0.93577218 |
| 43 | SIK3 | 0.93240662 |
| 44 | TAOK2 | 0.83260758 |
| 45 | IRAK3 | 0.81218897 |
| 46 | PDK1 | 0.80618764 |
| 47 | PRKCQ | 0.80040098 |
| 48 | MAP3K11 | 0.79359745 |
| 49 | MAP3K12 | 0.78519802 |
| 50 | FGFR3 | 0.74655951 |
| 51 | MAP3K1 | 0.74441781 |
| 52 | FGFR4 | 0.73015683 |
| 53 | TLK1 | 0.70380249 |
| 54 | MARK3 | 0.68988227 |
| 55 | MAPK7 | 0.68690392 |
| 56 | TESK2 | 0.67913144 |
| 57 | KDR | 0.67835195 |
| 58 | PDPK1 | 0.64949304 |
| 59 | MAPK12 | 0.64393094 |
| 60 | RIPK1 | 0.64194721 |
| 61 | CHUK | 0.63835556 |
| 62 | SCYL2 | 0.58033404 |
| 63 | ABL1 | 0.56561056 |
| 64 | CDK6 | 0.56259110 |
| 65 | FYN | 0.55777260 |
| 66 | STK10 | 0.55229979 |
| 67 | IRAK1 | 0.53777678 |
| 68 | PIM1 | 0.53414755 |
| 69 | TRPM7 | 0.50338602 |
| 70 | MOS | 0.47070402 |
| 71 | ACVR1B | 0.46897231 |
| 72 | HIPK2 | 0.44792477 |
| 73 | NEK9 | 0.44687750 |
| 74 | MAPK11 | 0.42907381 |
| 75 | PRKCD | 0.42759697 |
| 76 | TAOK1 | 0.42288937 |
| 77 | LRRK2 | 0.41794059 |
| 78 | MAP3K5 | 0.41744267 |
| 79 | EGFR | 0.40483735 |
| 80 | MAPKAPK2 | 0.40480927 |
| 81 | EPHB1 | 0.39384998 |
| 82 | DDR2 | 0.38757042 |
| 83 | CDK4 | 0.37366485 |
| 84 | IGF1R | 0.36373094 |
| 85 | EPHA3 | 0.34997272 |
| 86 | MAPK4 | 0.34929211 |
| 87 | SIK2 | 0.32987328 |
| 88 | STK24 | 0.32224857 |
| 89 | SMG1 | 0.31773680 |
| 90 | YES1 | 0.29981845 |
| 91 | ADRBK2 | 0.29817791 |
| 92 | RPS6KC1 | 0.29617105 |
| 93 | RPS6KL1 | 0.29617105 |
| 94 | DAPK3 | 0.29565201 |
| 95 | OXSR1 | 0.29121376 |
| 96 | MAP2K6 | 0.27654572 |
| 97 | PIM2 | 0.25713024 |
| 98 | DAPK1 | 0.23528884 |
| 99 | INSR | 0.22500485 |
| 100 | IRAK2 | 0.22116125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 5.28745639 |
| 2 | * Allograft rejection_Homo sapiens_hsa05330 | 4.86690997 |
| 3 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.54323459 |
| 4 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 4.48836104 |
| 5 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.10805266 |
| 6 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.78508840 |
| 7 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.78433758 |
| 8 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.19401282 |
| 9 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.97586300 |
| 10 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.88411989 |
| 11 | * Viral myocarditis_Homo sapiens_hsa05416 | 2.78590197 |
| 12 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.32402052 |
| 13 | * Tuberculosis_Homo sapiens_hsa05152 | 1.97806288 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87727401 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83306665 |
| 16 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.78188080 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60929744 |
| 18 | * Influenza A_Homo sapiens_hsa05164 | 1.58759755 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56021737 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47686751 |
| 21 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.47055544 |
| 22 | * Phagosome_Homo sapiens_hsa04145 | 1.46503677 |
| 23 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38080151 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.35453715 |
| 25 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.22267675 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.15461925 |
| 27 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14259910 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06182938 |
| 29 | Lysosome_Homo sapiens_hsa04142 | 1.02098981 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94990756 |
| 31 | Measles_Homo sapiens_hsa05162 | 0.94101538 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91545749 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87367190 |
| 34 | Malaria_Homo sapiens_hsa05144 | 0.86147567 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 0.85960239 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85875717 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.83953699 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76627612 |
| 39 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74894902 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72187853 |
| 41 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.69585311 |
| 42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69306737 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 0.67166294 |
| 44 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66649899 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65169694 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63880957 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.60950555 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.53589951 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.52506098 |
| 50 | Platelet activation_Homo sapiens_hsa04611 | 0.50431429 |
| 51 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.47752928 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.46702036 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44757022 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44437265 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.43180054 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40112594 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39110822 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39079750 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32084031 |
| 60 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31031792 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30013508 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28367692 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.27505783 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26886505 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22873578 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20301822 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.18283611 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.15568999 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14405178 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.14090897 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13855497 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.11775845 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11754985 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.11685129 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.10649593 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.10384049 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09690593 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08752706 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.06641067 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.05906780 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05713992 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.05373543 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.05019465 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.04275738 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.03843028 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.03193263 |
| 87 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.02304829 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02012727 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.01754407 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.01549329 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01541111 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.01135403 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.00820618 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.00636758 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.00531660 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.00352833 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0201813 |
| 98 | Prion diseases_Homo sapiens_hsa05020 | -0.0087341 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | -0.0059339 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0020910 |

